| Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression DC Perlman, WM El-Sadr, ET Nelson, JP Matts, EE Telzak, N Salomon, ... Clinical infectious diseases 25 (2), 242-246, 1997 | 386 | 1997 |
| Disinformation, misinformation and inequality-driven mistrust in the time of COVID-19: lessons unlearned from AIDS denialism J Jaiswal, C LoSchiavo, DC Perlman AIDS and Behavior 24, 2776-2780, 2020 | 264 | 2020 |
| Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis WM El-Sadr, DC Perlman, JP Matts, ET Nelson, DL Cohn, N Salomon, ... Reviews of Infectious Diseases 26 (5), 1148-1158, 1998 | 165 | 1998 |
| The syndemic of opioid misuse, overdose, HCV, and HIV: structural-level causes and interventions DC Perlman, AE Jordan Current HIV/AIDS Reports 15, 96-112, 2018 | 155 | 2018 |
| Predictors and outcome of multidrug-resistant tuberculosis N Salomon, DC Perlman, P Friedmann, S Buchstein, BN Kreiswirth, ... Clinical infectious diseases 21 (5), 1245-1252, 1995 | 152 | 1995 |
| Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci S Handwerger, DC Perlman, D Altarac, V McAuliffe Clinical infectious diseases 14 (3), 655-661, 1992 | 136 | 1992 |
| A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes WM El-Sadr, DC Perlman, E Denning, JP Matts, DL Cohn Clinical infectious diseases 32 (4), 623-632, 2001 | 127 | 2001 |
| “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001 DC Des Jarlais, T Perlis, K Arasteh, H Hagan, J Milliken, N Braine, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 35 (2), 158-166, 2004 | 121 | 2004 |
| Tuberculosis in drug users DC Perlman, N Salomon, MP Perkins, S Yancovitz, D Paone, DCD Jarlais Clinical Infectious Diseases 21 (5), 1253-1264, 1995 | 110 | 1995 |
| Widespread Dissemination of a Drug-Susceptible Strain of Mycobacterium tuberculosis CR Friedman, GC Quinn, BN Kreiswirth, DC Perlman, N Salomon, ... Journal of Infectious Diseases 176 (2), 478-484, 1997 | 102 | 1997 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 101 | 2022 |
| Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis AE Jordan, DC Perlman, J Neurer, DJ Smith, DC Des Jarlais, H Hagan International journal of STD & AIDS 28 (2), 145-159, 2017 | 101 | 2017 |
| Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program DC Des Jarlais, DG Fisher, JC Newman, BN Trubatch, M Yancovitz, ... American Journal of Public Health 91 (11), 1791-1792, 2001 | 100 | 2001 |
| “It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives D Frank, P Mateu-Gelabert, DC Perlman, SM Walters, L Curran, ... Harm Reduction Journal 18, 1-10, 2021 | 99 | 2021 |
| A randomized trial of a hepatitis care coordination model in methadone maintenance treatment CL Masson, KL Delucchi, C McKnight, J Hettema, M Khalili, A Min, ... American journal of public health 103 (10), e81-e88, 2013 | 97 | 2013 |
| A focus of Rocky Mountain spotted fever within New York City MP Salgo, EE Telzak, B Currie, DC Perlman, N Litman, M Levi, ... New England Journal of Medicine 318 (21), 1345-1348, 1988 | 96 | 1988 |
| Isospora belli Infection: Treatment with Pyrimethamine LM Weiss, DC Perlman, J Sherman, H Tanowitz, M Wittner Annals of internal medicine 109 (6), 474-475, 1988 | 95 | 1988 |
| The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis DC Perlman, Y Segal, S Rosenkranz, PM Rainey, RP Remmel, ... Clinical infectious diseases 41 (11), 1638-1647, 2005 | 93 | 2005 |
| Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma H Jin, JC Reed, STH Liu, H Ho, JP Lopes, NB Ramsey, O Waqar, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3594 …, 2020 | 80 | 2020 |
| Susceptibility to levofloxacin ofMycobacterium tuberculosisisolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance DC Perlman, WM El Sadr, LB Heifets, ET Nelson, JP Matts, K Chirgwin, ... Aids 11 (12), 1473-1478, 1997 | 75 | 1997 |
